The serum level of IL-12 was significantly higher in the tumor-bearing mice than in the tumor-free mice; moreover, the tumor-bearing mice also displayed a trend toward higher serum levels of IFNγ, IL-5, and IL-6 (Figure 3B). This evidence concerns the gene IFNG and neoplasm.